AER
LIVE

Serial Number

99668263

Owner

Auxilium Health, Inc.

Attorney

J. Derek Mason

Filing Date

Feb 24, 2026

Add to watchlist:

No watchlists yet
View on USPTO

AER Trademark

Serial Number: 99668263

AER is a trademark filed by Auxilium Health, Inc. on February 24, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently pending registration.

Owner Contact Info

Auxilium Health, Inc. (2 trademarks)

10000 Cedar Ave; GCIC Bldg; Suite GCIC2-110
Cleveland, OH 44195

Entity Type: 03

Trademark Details

Filing Date

February 24, 2026

Registration Date

Not Registered

Goods & Services

Surgical bandage; Bandages for dressings; Bandages for skin wounds; Biological preparations for the prevention and treatment of wound infections, surgical site infections, bone infections, soft tissue infections, and tissue damage; Biomaterial compositions for tissue regeneration and repair; Bandages impregnated with antimicrobial agents, gases, peptides, and therapeutics for tissue healing and infection control; Drug delivery agents in the form of aerogels, biomaterial scaffolds, and polymeric carriers that facilitate the delivery of pharmaceutical preparations; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Burn dressings; Sterile burn dressings; Antimicrobial coatings to treat the growth of mold, mildew, bacteria and fungus on various surfaces; Antiviral coatings to treat the growth of viruses on various surfaces; Biomaterial coatings for medical implants for infection prevention, tissue regeneration, or drug delivery purposes

Suture materials; Artificial biomaterials for augmentation of bone and tissue for medical purposes; Biomaterial-based medical devices for real-time monitoring of pH, biomarkers, and physiological conditions in wounds and tissues; Drug Delivery Patches sold without medication; Transdermal drug delivery patches sold without medication; Therapeutic facial mask; Implantable scaffolds comprising artificial materials for maintaining tissue contour; Coatings sold as an integral component of medical stents and other implantable medical devices; Implants coated for infection prevention, tissue regeneration, or drug delivery purposes.

Filing History

APPLICATION FILING RECEIPT MAILED
Feb 24, 2026 MAFR
NEW APPLICATION ENTERED
Feb 24, 2026 NWAP